Viromed Medical AG (XTER:VME) Total Stockholders Equity: €10.47 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:VME Viromed Medical AG XTER:VME
22 GF Score
Price €6.65
! 2 Warning Signs
View Full Analysis

What is Viromed Medical AG Total Stockholders Equity?

Viromed Medical AG XTER:VME +2.31% 22 Total Stockholders Equity is €10.47 Mil as of Dec. 2025. GuruFocus rates XTER:VME with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

Viromed Medical AG's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €10.47 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Viromed Medical AG's Book Value per Share for the quarter that ended in Dec. 2025 was €0.49. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Viromed Medical AG's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.00.

Viromed Medical AG  (XTER:VME) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Viromed Medical AG's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(10.474-0)/21.250
=0.49

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Viromed Medical AG's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.009 + 0) / 10.474
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viromed Medical AG Total Stockholders Equity Related Terms

Viromed Medical AG Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Viromed Medical AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viromed Medical AG Total Stockholders Equity Chart

Viromed Medical AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
0.25 20.08 19.97 9.27 10.47

Viromed Medical AG Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only 19.97 19.82 9.27 20.47 10.47
XTER:VME
22GF Score
Viromed Medical AG XTER:VME
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €10.47 Mil mean?
Viromed Medical AG (XTER:VME) has a Total Stockholders Equity of €10.47 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Viromed Medical AG and its competitors.
Is Viromed Medical AG's Total Stockholders Equity too high?
Viromed Medical AG's current Total Stockholders Equity is €10.47 Mil. Overall, Viromed Medical AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's Total Stockholders Equity compare to ABT and SYK?
Viromed Medical AG's Total Stockholders Equity of €10.47 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Viromed Medical AG and its competitors. Viromed Medical AG's current Total Stockholders Equity is €10.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (XTER:VME) has a current Total Stockholders Equity of €10.47 Mil. The current Total Stockholders Equity is €10.47 Mil. Viromed Medical AG's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Viromed Medical AG (XTER:VME), the current Total Stockholders Equity is €10.47 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viromed Medical AG Business Description

Other Exchanges VME:GermanyVME:Germany
Address Hauptstrasse 105, Rellingen, Pinneberg, SH, DEU, 25462
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
22GF Score

Get the complete analysis for XTER:VME

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.65
Price